(Q44341133)

2 December 2017

title

Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys (English)

1 reference

2 December 2017

Effect of opioid receptor antagonists on hypothalamic–pituitary–adrenal activity in rhesus monkeys (English)

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

23 December 2023

0 references

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

23 December 2023

1

K. L. Williams

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689609

23 December 2023

2

M. C Holden Ko

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689609

23 December 2023

author name string

K. C. Rice

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689609

23 December 2023

J. H. Woods

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12689609

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12689609

23 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0306453002000379?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

https://api.elsevier.com/content/article/PII:S0306453002000379?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

23 December 2023

published in

Psychoneuroendocrinology

1 reference

2 December 2017

volume

28

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

513-528

1 reference

Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Effects of long-term therapy with naltrexone on body weight in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Naltrexone increases the latency to drink alcohol in social drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Inhibitory action of a met-enkephalin on ACTH release in man

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement☆

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

The discriminative stimulus effects of naloxone and naltrexone in morphine-treated rhesus monkeys: comparison of oral and subcutaneous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Different opioid mechanisms are involved in the modulation of ACTH and gonadotrophin release in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Naloxone-induced ACTH release: mechanism of action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Acute effects of nalmefene on LH, prolactin, and testosterone in male rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Neuroendocrine effects of endogenous opioid peptides in human subjects: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Naltrexone-induced alterations in human ethanol intoxication.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Alcohol effects on naltrexone-induced stimulation of pituitary, adrenal, and gonadal hormones during the early follicular phase of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Non-specific effect of naltrexone on ethanol consumption in social drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2802%2900037-9

7 January 2021

Naltrexone, an opioid blocker, alters taste perception and nutrient intake in humans

3

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys

23 December 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

A controlled trial of naltrexone in obese humans

23 December 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor

23 December 2023

37

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action

23 December 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox

23 December 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(02)00037-9

23 December 2023

Identifiers

1 reference

2 December 2017

1 reference